Utah Medical Products Inc
UTMD· Nasdaq
Released Oct 26, 2021, during market hours
10-Q filed Nov 12, 2021, 43 days after period end · 0001811884-21-000016
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $12.57M | $10.48M | $12.49M | $10.39M |
| Net Income | $4.21M | $2.93M | $3.71M | $6.76M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.15 |
| $0.80 |
| $0.99 |
| $1.80 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.